These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 23155750)
1. [MODY diabetes--a monogenic developmental and functional disturbance of pancreatic beta cells]. Miettinen PJ; Tuomi T Duodecim; 2012; 128(19):1989-98. PubMed ID: 23155750 [TBL] [Abstract][Full Text] [Related]
2. [Glucokinase gene abnormalities in maturity-onset diabetes of the young (MODY) and late-onset NIDDM]. Odawara M Nihon Rinsho; 1994 Oct; 52(10):2580-6. PubMed ID: 7983782 [TBL] [Abstract][Full Text] [Related]
3. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Owen K; Hattersley AT Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):309-23. PubMed ID: 11554773 [TBL] [Abstract][Full Text] [Related]
4. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults. Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320 [TBL] [Abstract][Full Text] [Related]
5. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Gloyn AL Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946 [TBL] [Abstract][Full Text] [Related]
6. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent. Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167 [TBL] [Abstract][Full Text] [Related]
7. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY). Cao H; Shorey S; Robinson J; Metzger DL; Stewart L; Cummings E; Hegele RA Hum Mutat; 2002 Dec; 20(6):478-9. PubMed ID: 12442280 [TBL] [Abstract][Full Text] [Related]
8. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729 [TBL] [Abstract][Full Text] [Related]
9. Glucokinase mutations in young children with hyperglycemia. Codner E; Deng L; Pérez-Bravo F; Román R; Lanzano P; Cassorla F; Chung WK Diabetes Metab Res Rev; 2006; 22(5):348-55. PubMed ID: 16444761 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic and pathomorphological characteristics of a novel mutant mouse model for maturity-onset diabetes of the young type 2 (MODY 2). van Bürck L; Blutke A; Kautz S; Rathkolb B; Klaften M; Wagner S; Kemter E; Hrabé de Angelis M; Wolf E; Aigner B; Wanke R; Herbach N Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E512-23. PubMed ID: 19952346 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY). Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481 [TBL] [Abstract][Full Text] [Related]
13. Genetic and clinical characteristics of maturity-onset diabetes of the young. Giuffrida FM; Reis AF Diabetes Obes Metab; 2005 Jul; 7(4):318-26. PubMed ID: 15955117 [TBL] [Abstract][Full Text] [Related]
14. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young. Mantovani V; Salardi S; Cerreta V; Bastia D; Cenci M; Ragni L; Zucchini S; Parente R; Cicognani A Hum Mutat; 2003 Oct; 22(4):338. PubMed ID: 12955723 [TBL] [Abstract][Full Text] [Related]
15. Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online. Guazzini B; Gaffi D; Mainieri D; Multari G; Cordera R; Bertolini S; Pozza G; Meschi F; Barbetti F Hum Mutat; 1998; 12(2):136. PubMed ID: 10694920 [TBL] [Abstract][Full Text] [Related]
17. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Hattersley AT Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859 [TBL] [Abstract][Full Text] [Related]
18. Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients. Hwang JS; Shin CH; Yang SW; Jung SY; Huh N Diabetes Res Clin Pract; 2006 Oct; 74(1):75-81. PubMed ID: 16632067 [TBL] [Abstract][Full Text] [Related]
19. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2. Loomba-Albrecht LA; Jame M; Bremer AA Diabetes Res Clin Pract; 2010 Mar; 87(3):e23-5. PubMed ID: 20015564 [TBL] [Abstract][Full Text] [Related]
20. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L; Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]